gabapentin has been researched along with Amphetamine-Related Disorders in 2 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Amphetamine-Related Disorders: Disorders related or resulting from use of amphetamines.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients seeking treatment for methylamphetamine dependence must cope with drug cravings as they engage in psychosocial treatments." | 2.76 | A controlled trial of flumazenil and gabapentin for initial treatment of methylamphetamine dependence. ( Baron, M; Hanselka, LL; Urschel, HC, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Urschel, HC | 1 |
| Hanselka, LL | 1 |
| Baron, M | 1 |
| Ling, W | 1 |
| Shoptaw, S | 1 |
| Hillhouse, M | 1 |
| Bholat, MA | 1 |
| Charuvastra, C | 1 |
| Heinzerling, K | 1 |
| Chim, D | 1 |
| Annon, J | 1 |
| Dowling, PT | 1 |
| Doraimani, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Double-Blind, Placebo Controlled Trial of Prometa Pharmacotherapy for the Treatment of Methamphetamine Abuse[NCT00260481] | Phase 2/Phase 3 | 120 participants (Actual) | Interventional | 2006-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for gabapentin and Amphetamine-Related Disorders
| Article | Year |
|---|---|
A controlled trial of flumazenil and gabapentin for initial treatment of methylamphetamine dependence.
Topics: Adolescent; Adult; Amines; Amphetamine-Related Disorders; Anticonvulsants; Behavior, Addictive; Cycl | 2011 |
Double-blind placebo-controlled evaluation of the PROMETA™ protocol for methamphetamine dependence.
Topics: Adult; Amines; Amphetamine-Related Disorders; Cyclohexanecarboxylic Acids; Double-Blind Method; Drug | 2012 |